The use of pluripotent stem cells to generate diagnostic tools for transfusion medicine
Hyun Hyung An(University of Pennsylvania), Stella T. Chou(Children's Hospital of Philadelphia), Connie M. Westhoff(New York Blood Center), Deborah L. French(Children's Hospital of Philadelphia), Osheiza Abdulmalik(Children's Hospital of Philadelphia), Jean Ann Maguire(Children's Hospital of Philadelphia), Alyssa Gagne(Children's Hospital of Philadelphia), Paul Gadue(Children's Hospital of Philadelphia), Giulia Pavani(Children's Hospital of Philadelphia)
Cited by 25
Related Papers
Wnt and TGF-β signaling are required for the induction of an <i>in vitro</i> model of primitive streak formation using embryonic stem cells
|Proceedings of the National Academy of Sciences|2006|554
Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys
|Science Translational Medicine|2013|346
In vivo hematopoietic stem cell modification by mRNA delivery
|Science|2023|321
5‐hydroxymethyl‐2‐furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells<sup>†,‡</sup>
|British Journal of Haematology|2005|244